|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Flavonol eaffeoylglyco- sides as ct-glucosidase inhibitors from Spiraea cantoniensis flower显示文摘 | Yoshida K Hishida A lida O | 2008 | Agric Food Chem2008，56，12： | 1 |
| 2 | A randomized open-label comparative study of conventional therapy versus mizoribine on lay therapy in patients with steroid-resistant nephrotie syndrome (post marketing survey) 显示文摘 | Shibasaki T Koyama A Hishida A | 2004 | Clin Exp Nephrol2004，8，： | 1 |
| 3 | Determinants for the prognosis of acute renal disorders that developed during or after treatment with edaravone显示文摘 | Hishida A | 2009 | Clin Exp Nephrol2009，13，2： | 1 |
| 4 | Smoking behavior and risk of Helicobacter pylori infection,gastric atrophy and gastric cancer in Japanese显示文摘 | Hishida A Matsuo K Goto Y | 2010 | Asian Pac J Cancer Prev2010，11，3： | 1 |
| 5 | Turbulent flow past a bubble and an ellipsoid using shadowimage and PIV techniques显示文摘 | Tokuhiro A Maekawa M Iizuka K Hishida K Maeda M | 1998 | International Journal of Multiphase Flow1998，，24： | 1 |
| 6 | Heat transfer enhancement to the drag-reducing flow of surfactant solution in two-dimensional channel with mesh-screen inserts at the inlet 显示文摘 | Li Peiwen Kawaguchi Y Daisaka H Yabe A Hishida K Maeda M | 2001 | Journal of Heat Transfer2001，123，4： | 1 |
| 7 | Mechanisms of steroid enhanced proteinuria in nephrotic patients 显示文摘 | Kumagai H Hishida A Nagase A | 1987 | Jpn J Mephrol1987，29，3： | 1 |
| 8 | Flavonol caffeoyl- glycosides as ct-glucosidase irthibitors from Spiraea cantoniensis flower 显示文摘 | Yoshida K Hishida A Iida O | 2008 | J Agric Food Chem2008，56，12： | 1 |
| 9 | Impact of carotid atherosclerosis on long- term mortality in chronic hemodialysis patients显示文摘 | A Takita T Maruyama Y Kumagai H Hishida A | 2003 | Kidney Int2003，64，： | 1 |
| 10 | Measurement in the wake region of two bubbles in close proximity by combined shadow image and PIV techniques显示文摘 | TOKUHIRO A FUJIWARA A HISHIDA K | 1999 | ASME Journal of Fluids Engineering1999，121，1： | 1 |
| 11 | Clinical analysis of 207 patients who developed renaldisorders during or after treatment with edaravone reported duringpost-marketing surveillance 显示文摘 | Hishida A | 2007 | Clin Exp Nephrol2007，11，4： | 1 |
| 12 | Defective electron transfer in complexes Ⅰ and Ⅳ in patients with aceruloplasminemia 显示文摘 | Kohno S Miyajima H Takahashi Y Suzuki H Hishida A | 2000 | Journal Neurological Sciences2000，182，1： | 1 |
| 13 | Toll-Like receptor 4 + 3725 G/ C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese 显示文摘 | Hishida A Matsuo K Goto Y | 2009 | Helieobaeter2009，14，1： | 1 |
| 14 | A random- ized open-label comparative study of conventional therapy versus mizoribine on lay therapy in patients with steroid-re- sistant nephrotic syndrome (postmarketing survey) 显示文摘 | SHIBASAKI T KOYAMA A HISHIDA A | 2004 | Clin Exp Nephro12004，8，： | 1 |
| 15 | Determinants for the prognosis of acute renal disordersthat developed during or after treatment with edaravone显示文摘 | Hishida A | 2009 | ClinExp Nephrol2009，13，2： | 1 |
| 16 | Polymorphisms in genes encod- ing antioxidant enzymes (SOD2, CAT, GPx, TXNRD, SEPP1, SEP15 and SELS) and risk of chronic kidney disease in Japanese-cross-sec- tional data from the J-MICC study 显示文摘 | Hishida A Okada R Naito M | 2013 | J Clin Biochem Nutr2013，53，1： | 1 |
| 17 | An absolute re- quirement of fructose 1,6-bisphosphate for the Lactoba- cillus casei L-lactate dehydrogenase activity induced by a single amino acid substitution显示文摘 | Arai K Hishida A Ishiyama M | 2002 | Protein Engineering2002，15，1： | 1 |
| 18 | Bubble deformation and flow structure measured by shadow images and PIV/LIF显示文摘 | Fujiwara A Danmoto Y Hishida K | 2004 | Experiments in Fluids2004，36，2： | 1 |
| 19 | Nephrotic syndrome: pathophysiology, classification and diagnostic criteria 显示文摘 | Togawa A Yamamoto T Hishida A | 2004 | Nihon Rinsho2004，62，10： | 1 |
| 20 | Mechanisms of altered renal perfusion in the early stage of obstructive jaundice显示文摘 | Hishida A Honda N Sudo M | 1980 | Kidney Int1980，17，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员